Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
20 November 2023 |
Main ID: |
NCT02531087 |
Date of registration:
|
20/08/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Urinary Biomarkers of OI Pathobiology
|
Scientific title:
|
Cross-Linked Collagen Peptides as a Urinary Biomarker of OI Pathobiology |
Date of first enrolment:
|
September 2015 |
Target sample size:
|
25 |
Recruitment status: |
Active, not recruiting |
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02531087 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Canada
|
United States
| | | | | | |
Contacts
|
Name:
|
David Eyre, Ph.D. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Washington |
|
Name:
|
Frank Rauch, M.D. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Shriners Hospital for Children |
|
Name:
|
Vernon Reid Sutton, M.D. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Baylor College of Medicine |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- To be able to participate, you must:
Be enrolled in The Longitudinal Study of OI (NTC #02432625) and have one of the following
genetic mutations:
- glycine substitution mutations in COL1A1 or COL1A2
- haploinsufficient mutation in COL1A1 or COL1A2
- mutations in CRTAP, PPIB, or LEPRE1
- mutations in FKBP10 or SERPINH1
- mutations in (SERPINF1, WNT1, or IFITM5)
- dominant negative glycine substitutions and haploinsufficient mutations in COL1A1, and
COL1A2
If you are serving as a control, you must not be related to an individual with OI.
Exclusion Criteria:
- You cannot participate if:
- You are unable to comply with the sample collection schedule.
- You are related to one of the OI subjects and would like to serve as a control
subject.
- You have vertebral instrumentation or spinal deformities where we cannot assess lumbar
spine aBMD.
- You have a history of recent fracture (< 3 months).
- You have serum creatinine above 1x upper limits of normal.
- You have abnormal kidney function.
- You are using Minoxidil.
- You are unable to provide a urine sample readily.
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Osteogenesis Imperfecta
|
Primary Outcome(s)
|
HP/LP Ratio
[Time Frame: 5 Years]
|
Secondary Outcome(s)
|
HP/LP ratio
[Time Frame: 5 Years]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|